More recently, Sahyon and coworkers proved in vitro that combination therapy comprising quercetin (27.98 ± 1.74 μg/mL) and sulfamethoxazole exerts anticancer effects by inducing apoptosis via caspase-3 and NF-κB gene regulation and exhibits selective toxicity against cancer cells [47]. Here, NFKB1 is linked to cancer.